Escort aptamers: A delivery service for diagnosis and therapy

Journal of Clinical Investigation

Volumn 106, Issue 8, 2000, Pages 923-925

  Hicke, Brian J ^a   Stephens, Andrew W ^a  

^a GILEAD SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; APTAMER; OLIGONUCLEOTIDE; RADIOISOTOPE; UNCLASSIFIED DRUG;

ANTIBODY AFFINITY; ARTICLE; BINDING AFFINITY; BONE MARROW TOXICITY; CLEARANCE; DIAGNOSTIC VALUE; DRUG DELIVERY SYSTEM; HALF LIFE TIME; IMMUNE RESPONSE; IMMUNOGENICITY; ISOTOPE LABELING; MOLECULAR SIZE; MOLECULAR STABILITY; PLASMA CLEARANCE; PLASTICITY; PRIORITY JOURNAL; PROTEIN ISOLATION; PROTEIN TARGETING; STRUCTURE ANALYSIS; SYNTHESIS; TARGET ORGAN; TRANSLATION REGULATION;

EID: 0033790673     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/jci11324     Document Type: Article

References (29)

1. Systematic Evolution of Ligands by EXponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase
2. In vitro selection of RNA molecules that bind specific ligands
3. Oligonucleotides as research, diagnostic, and therapeutic agents
4. Aptamers as tools in molecular biology and immunology
5. Diversity of oligonucleotide functions
6. 2'-Fluoropyrimidine RNA-based aptamers to the 165-amino acid form of vascular endothelial growth factor (VEGF165). Inhibition of receptor binding and VEGF-induced vascular permeability through interactions requiring the exon 7-encoded domain
7. Aptamers: An emerging class of molecules that rival antibodies in diagnostics
8. Developing aptamers into therapeutics
9. Clinical radioimmunotherapy
10. Generating improved single-chain Fv molecules for tumor targeting
11. Tumor localization of anti-CEA single-chain Fvs: Improved targeting by non-covalent dimers
12. Pretargeting of renal cell carcinoma: Improved tumor targeting with a bivalent chelate
13. Antibody-guided three-step therapy for high grade glioma with yttrium-90 biotin
14. Cure of human carcinoma xenografts by a single dose of pretargeted yttrium-90 with negligible toxicity
15. Small peptides radiolabeled with 99mTc
16. Keeping pace with genomics through combinatorial chemistry
17. In vivo imaging of inflammation using an aptamer inhibitor of human neutrophil elastase
18. A SELEX primer
19. Making antibodies by phage display technology
20. In vitro selection and evolution of functional proteins by using ribosome display
21. A high throughput platform for systematic evolution of ligands by exponential enrichment (SELEX)
22. Automated RNA selection
23. The joys of in vitro selection: Chemically dressing oligonucleotides to satiate protein targets
24. Kinetic characterization of ribonuclease-resistant 2'-modified hammerhead ribozymes
25. Tc-99m-labeling of modified RNA
26. Increased affinity leads to improved selective tumor delivery of single-chain Fv antibodies
27. Anti-L-selectin oligonucleotide ligands recognize CD62L-positive leukocytes: Binding affinity and specificity of univalent and bivalent ligands
28. Anti-L-selectin aptamers: Binding characteristics, pharmacokinetic parameters, and activity against an intravascular target in vivo
29. High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: Therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model